Spots Global Cancer Trial Database for Building Resiliency Among Caregivers of Curvivors and Metavivors

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Building Resiliency Among Caregivers of Curvivors and Metavivors

Official Title: Building Resiliency Among Caregivers of Curvivors and Metavivors: A Pilot Randomized Trial

Study ID: NCT05702723

Conditions

Stress

Cancer Diagnosis

Distress, Emotional

Interventions

Smart-3RP

Enhanced Usual Care

Study Description

Brief Summary: The main purpose of this research study is to assess the feasibility and participants' satisfaction of the Stress Management and Resiliency - Relaxation Response Resiliency Program (SMART-3RP) and compare this treatment with SMART-3RP versus referral to a group-based, online support group to see which is better for improving resilience and decreasing distress of participants with cancer and their caregivers. The name of the study intervention involved in this study is: Smart-3RP (virtual, mind-body group treatment program).

Detailed Description: This pilot, randomized controlled trial assesses the feasibility, acceptability, and efficacy of the Stress Management and Resiliency - Relaxation Response Resiliency Program (SMART-3RP) for improving resiliency and decreasing distress among caregivers and cancer survivors compared to enhanced usual care. Participants will be randomly assigned into one of the study groups: Smart-3RP versus referral to a group-based, online support group. Randomization means that a participant is placed into a group by chance. Participation in this study is expected to last about 180 days. It is expected about 96 people made up of 48 patients and 48 caregivers will take part in this research study. The National Institutes of Health (NIH) is supporting this research by providing funding.